0HF3.LSE Cencora

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
40.9x
P/B
-
ROE
129.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is 0HF3.LSE undervalued?

Graham number

The Graham number of Cencora cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cencora fundamental analysis

No fundamental analysis for Cencora yet.

Cencora stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and o…

Full company profile